Taav Biomanufacturing Solutions is a contract development and manufacturing organisation (CDMO) that specialises in producing synthetic DNA, specifically dbDNA™, which serves as an alternative to traditional plasmid DNA for the manufacture of adeno-associated virus (AAV). Founded in 2019, Taav positions dbDNA™ as a disruptive technology within the DNA market, aiming to establish a new industry standard for transfection-based AAV production. Their innovative synthetic process allows for high yields at small scales, which effectively shortens manufacturing timelines, facilitates quicker AAV production, and enhances safety by eliminating residual bacterial sequences associated with plasmid DNA in the final AAV product.

Services include:
– Production of synthetic DNA (dbDNA™)
– Development and manufacturing of adeno-associated viruses (AAV)
– Contract development and manufacturing services (CDMO)
– Optimisation of manufacturing processes for efficiency and yield

Taav Biomanufacturing Solutions is committed to advancing the field of AAV production through their cutting-edge solutions. For more information, please visit taav.com.